Neuroone Medical Company Insiders

Neuroone Medical Management Team Effectiveness

The company has return on total asset (ROA) of (1.4333) % which means that it has lost $1.4333 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.4913) %, meaning that it created substantial loss on money invested by shareholders. Neuroone Medical's management efficiency ratios could be used to measure how well Neuroone Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Neuroone Medical's Return On Equity is projected to drop based on the last few years of reporting. At present, Neuroone Medical's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 377 K, whereas Total Assets are forecasted to decline to about 3 M. The current year's Common Stock Shares Outstanding is expected to grow to about 28.1 M, whereas Net Loss is forecasted to decline to (9.4 M).

Neuroone Medical Workforce Comparison

Neuroone Medical Insider Trading

Neuroone Medical Notable Stakeholders

The success or failure of an entity such as Neuroone Medical Tec often depends on how effective the management is. Neuroone Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Neuroone management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Neuroone management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Neuroone Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Neuroone Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Neuroone Medical's management manipulating its earnings.

When running Neuroone Medical's price analysis, check to measure Neuroone Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuroone Medical is operating at the current time. Most of Neuroone Medical's value examination focuses on studying past and present price action to predict the probability of Neuroone Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuroone Medical's price. Additionally, you may evaluate how the addition of Neuroone Medical to your portfolios can decrease your overall portfolio volatility.